Harding Loevner LP Abcam PLC Transaction History

Harding Loevner LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$12.62 - $24.47 $38.5 Million - $74.7 Million	-3,053,728 Reduced 22.22%	10,687,444 $262 Million
Q1 2023 May 15, 2023	SELL	$12.98 - $17.1 $836,119 - $1.1 Million	-64,416 Reduced 0.47%	13,741,172 $185 Million
Q4 2022 Feb 14, 2023	BUY	$13.92 - $17.0 $187 Million - $229 Million	13,461,099 Added 3907.56%	13,805,588 $215 Million
Q3 2022 Nov 14, 2022	SELL	$13.36 - $16.75 $92,825 - $116,379	-6,948 Reduced 1.98%	344,489 $5.16 Million
Q2 2022 Aug 15, 2022	SELL	$12.69 - $19.25 $293,913 - $445,849	-23,161 Reduced 6.18%	351,437 $5.08 Million
Q1 2022 May 16, 2022	BUY	$15.5 - $23.89 $8,168 - $12,590	527 Added 0.14%	374,598 $6.82 Million
Q4 2021 Feb 14, 2022	BUY	$20.04 - $23.84 $299,778 - $356,622	14,959 Added 4.17%	374,071 $8.81 Million
Q3 2021 Nov 15, 2021	BUY	$17.38 - $21.54 $13,643 - $16,908	785 Added 0.22%	359,112 $7.28 Million
Q2 2021 Aug 16, 2021	SELL	$18.47 - $22.11 $28,646 - $34,292	-1,551 Reduced 0.43%	358,327 $6.82 Million
Q1 2021 May 17, 2021	BUY	$19.22 - $24.3 $6.86 Million - $8.68 Million	357,130 Added 12996.0%	359,878 $6.92 Million
Q4 2020 Feb 16, 2021	BUY	$18.2 - $22.45 $50,013 - $61,692	2,748 New	2,748 $59,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Harding Loevner LP, based on Form 13F filings with the SEC.

Stay updated on Harding Loevner LP with notifications on news.